Are Polymorphic Markers within the α-1-Antitrypsin Gene Associated with Risk of Human Immunodeficiency Virus Disease?

Journal of Infectious Diseases

Volumn 188, Issue 8, 2003, Pages 1205-1208

  Hayes, Vanessa M ^a,b   Gardiner Garden, Margaret ^b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; GENE PRODUCT; PROTEIN PI; SERPIN A1; UNCLASSIFIED DRUG;

AAT GENE; ADULT; AFRICA; ALLELISM; ARTICLE; CODING; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE MARKER; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POPULATION DISTRIBUTION; POPULATION GENETICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; ALPHA 1-ANTITRYPSIN; ASIAN CONTINENTAL ANCESTRY GROUP; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0242333154     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378641     Document Type: Article

References (13)

1. Blank CA, Brantly M. Clinical features and molecular characteristics of α1-antitrypsin deficiency. Ann Allergy 1994; 72:105-20.
2. Fox PC, Wolff A, Yeh CK, Atkinson JC, Baum BJ. Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 1988; 166:635-7.
3. McNeely TB, Dealey M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus type 1 activity in vitro. J Clin Invest 1995; 96:456-64.
4. Shapiro L, Pott GB, Ralston AH. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J 2001; 15:115-22.
5. Bristow CL, Patel H, Arnold RR. Self antigen prognostic for human immunodeficiency virus disease progression. Clin Diagn Lab Immunol 2001; 8:937-42.
6. Hayes VM. Genetic diversity of the alpha-1-antitrypsin gene in Africans identified using a novel genotyping assay. Hum Mutat 2003; 22: 59-66.
7. Hayes VM, Petersen DC, Scriba TJ, Zeier M, Grimwood A, Janse van Rensburg E. African-based CCR5 single-nucleotide polymorphism associated with HIV-1 disease progression. AIDS 2002; 16:2229-31.
8. Klein MR, Miedema F. Long term survivors of HIV-1 infection. Trends Microbiol 1995; 3:386-91.
9. Just JJ. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome. Hum Immunol 1995; 44:156-69.
10. Garzino-Demo A, Devico AL, Gallo RC. Chemokine receptors and chemokines in HIV infection. J Clin Immunol 1998; 18:243-55.
11. Dean M, Carrington M, Winkler C, et al. Genetic restriction of the HIV-1 infection by a deletion allele of the CKR5 structural gene. Science 1996; 273:1856-62.
12. Petersen DC, Kotze MJ, Zeier MD, et al. Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay. AIDS 2001; 15:171-7.
13. Shen LX, Basilion JP, Stanton VP. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci USA 1999; 96:7871-6.